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A depletion of reduced glutathione (GSH) has been observed in pathological conditions and in aging. Measuring GSH in
tissues using mouse models is an excellent way to assess GSH depletion and the potential therapeutic efficacy of drugs used to
maintain and/or restore cellular redox potential. A high performance liquid chromatography (HPLC)method for the simultaneous
determination of GSH and cysteine (Cys) in mouse organs was validated according to USA and European standards. The method
was based on separation coupled with ultraviolet detection and precolumn derivatization with 5,5󸀠-dithiobis-(2-nitrobenzoic acid)
(DTNB). The required validation parameters, that are, selectivity, linearity, lower limit of quantification, precision, accuracy,
recovery, and stability, were studied for spleen, lymph nodes, pancreas, and brain. The results showed that the lower limits of
quantification were 0.313 𝜇M and 1.25 𝜇M for Cys and GSH, respectively. Intraday and interday precisions were less than 11% and
14%, respectively, for both compounds. The mean extraction recoveries of Cys and GSH from all organs were more than 93% and
86%, respectively. Moreover, the stability of both analytes during sample preparation and storage was demonstrated. The method
was accurate, reliable, consistent, and reproducible and it was useful to determine Cys and GSH in the organs of different mouse
strains.
1. Introduction
GSH is the prevalent nonprotein thiol in animal cells and the
most abundant antioxidant in aerobic cells. It is implicated in
many cellular functions, such as degradation and synthesis of
proteins andDNAor detoxification of toxins and carcinogens
[1].
A depletion or an imbalance of GSH has been observed
in several pathological conditions such as neurodegenerative
diseases, cystic fibrosis, viral infections, AIDS, diabetes,
cancer, and ageing [2, 3]. Moreover, GSH content plays an
important role in regulating cellular immune response [4].
Under conditions of moderate oxidative stress, oxidation
of Cys residues can lead to the reversible formation of
mixed disulfides between protein thiol groups and low-
molecular-mass thiols (S-thiolation), particularly with GSH
(S-glutathionylation). S-Glutathionylated proteins can be
readily reduced to free thiol groups when normal cellular
redox status is recovered by reducing agents [5]. Moreover,
to restore GSH levels, cells can use Cys causing decrease
in this amino acid content [6]. Hence, GSH and Cys could
be considered important biomarkers to assess the degree of
oxidative damage and the correct redox state replenishment.
Development and validation of simple analytical methods
to measure GSH and other thiols in biological samples
are a prerequisite to obtain an accurate assessment of the
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degree of oxidative damage as well as indication of disease
progression and consequently evaluation of the effectiveness
of antioxidant therapy [5]. In fact, molecules able to augment
intracellular GSH levels have been proposed as potential
therapeutic tools to combat several diseases and in new
immunomodulatory approaches [7]. Hence, determining
thiol status is important to understand the basic biochemical
response of cells during a pathological condition as well as
during ageing and the capacity of drugs to restore cellular
glutathione homeostasis.
A lot of methods for measuring thiol species in biological
fluids and tissue samples have been evolved [8–15]. However,
a few methods have been validated according to US and
European standards [9, 10].
Our goal was to validate a simple and rapid method,
which allowed the simultaneous determination of the main
thiol species, such as GSH and Cys, in different mouse
organs by using reversed-phase high performance liquid
chromatography (RP-HPLC) with ultraviolet detection. The
method was based on precolumn derivatization with Ell-
man’s reagent [5,5󸀠-dithiobis-(2-nitrobenzoic acid), (DTNB)]
which reactedwith R-SH to form the R-TNB derivative which
was separated and quantified. Among the different available
derivatizationmethods, the quantification of thiols by DTNB
was selected because it has been described to be particularly
simple and useful in the study of thiol redox state and protein
glutathionylation [16]. Moreover, RP-HPLC method has the
advantage of being accessible to most analytical laboratories
since they do not require expensive dedicated instruments.
Themethod proved good in quality and performance and
allowed determining GSH and Cys in the organs of three
mouse strains (ICR (CD-1), BALB/cJ, and C57BL/6N mice)
commonly used in preclinical studies.
2. Materials and Methods
2.1. Chemicals. Cys, GSH, and DTNB were purchased from
Sigma-Aldrich (Sigma-Aldrich Co., St. Louis, MO, USA).
Acetonitrile was acquired from Carlo Erba (Carlo Erba
Reagenti, Milan, Italy).
2.2. Ethics Statement. Housing and treatment of mice were in
compliance with the recommendations in the Guide for the
Care and Use of Laboratory Animals by the Health Ministry,
law 116, 1992. Experiments were approved by the Committee
on the Ethics of Animal Experiments of the University of
Urbino “Carlo Bo” and Sapienza University. The animals
were suppressed by carbon dioxide. Every effort was made to
minimize animal suffering and to limit the number of animals
used.
2.3. Animals. Four-week-old female ICR (CD-1) and six-
week-old female BALB/cJ mice were purchased from Harlan
Nossan (Milan, Italy), while four-week-old female C57BL/6N
mice were purchased from Charles River (Lecco, Italy).
Throughout the study, the mice were kept at a temperature
of 22 ± 1∘C and a relative humidity of 60 ± 5%, with a 12 h
light/dark cycle and 12 air changes/h.
2.4. High Performance Liquid Chromatography Apparatus.
Cys and GSH determination in different organs was per-
formed throughHPLC JascoModel LG-980-02 (Jasco Europe
S.R.L., Cremella (LC), Italy). The separation was performed
on a Teknokroma Tracer Excel 120 column ODSA 5 𝜇m
15 × 0.46 (Teknokroma Analitica S.A., Barcelona, Spain)
protected by a Teknokroma Tracer Excel guard column ODS
10 × 3.2mm (Teknokroma Analitica S.A., Barcelona, Spain).
The mobile phase consisted of KH
2
PO
4
solution (10mM,
pH 6.0) (buffer A) and buffer A containing acetonitrile
(60% v/v) (buffer B). All buffer solutions after preparation
and pH adjustment as well as standards were filtered through
0.22𝜇m Acrodisc Syringe Filters (Pall Life Sciences, Ann
Arbor, MI, USA). The elution conditions were as follows:
10min 100% buffer A, followed by an increase to 100% buffer
B in 15min; this condition was maintained for 5min. The
gradient was returned to 100% buffer A in 3min, and the
column was regenerated with 100% buffer A for another
4min before injection of the next sample. The flow rate was
1mL/min, the injection volume was 50𝜇L, and detection was
at 330 nm. Analyses were performed at 25∘C and quantitative
measurements were obtained by injection of standards of
known concentration.
2.5. Sample Preparation. The organs (spleen, lymph nodes,
brain, and pancreas) were quickly excised at the same time
of the day (9 a.m.–11 a.m.), 10–20mgs were immediately put
into an Eppendorf microcentrifuge tube containing 500𝜇L
of precipitating solution (100mL containing 1.67 g of glacial
metaphosphoric acid, 0.2 g of disodium EDTA, and 30 g of
NaCl).The sample was first homogenized through a grinding
pestle and then sonicated at 50 watts for 10 seconds (B. Braun
Labsonic U, B. Braun Biotech International); all of these
procedures were carried out in ice. The sample was kept in
ice for 10min and then centrifuged at 12,000×g for 10min at
4∘C. Fifteen 𝜇L of 0.3MNa
2
HPO
4
were added to 60 𝜇L of the
acid extract and immediately after 45𝜇L DTNB were added.
DTNB solution was prepared dissolving 20mg of DTNB in
100mL of sodium citrate solution (1%w/v). The mixture was
stirred for 1 minute at room temperature (RT) and then left at
RT for another 5 minutes and finally used for Cys and GSH
determination by RP-HPLC.
2.6. Method Validation. Themethod was validated according
to the currently accepted US-FDA Bioanalytical Method Val-
idation Guidance and European Medicines Agency Guide-
line on Bioanalytical Method Validation with respect to
selectivity, linearity, lower limit of quantification (LLOQ),
precision and accuracy, recovery, and stability. The method
was validated with organs of ICR (CD-1) mice. Selectivity
was assessed by comparing chromatograms of standard
preparations with those of mouse organs.
Calibration curves for GSH and Cys were obtained by
serial dilutions from a stock solution. The standards were
diluted either in water or in the precipitating solution used to
precipitate organ proteins. The exact concentrations of stan-
dard solutions of GSH and Cys were obtained through spec-
trophotometer readings at 412 nm following the procedure
described by Beutler [17]. The linearity of each calibration
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Figure 1: HPLC chromatograms of standards of Cys and GSH (20𝜇M) (a) and of an extract of mouse spleen (b). The exact concentrations
of standard solutions of Cys and GSH were obtained through spectrophotometer readings at 412 nm as described in Section 2.
curve was determined by plotting the peak area (𝑦) versus the
corresponding concentration (𝑥). The LLOQ was defined as
the lowest calibration standard on the calibration curve with
acceptable accuracy within 20% and precision below 20%.
The precision and accuracy of the method were assessed
by at least five replicate analyses of organ samples spiked with
GSH and Cys ranging from low to high concentrations of the
calibration curve. The precision was evaluated in the same
analytical run (intraday assay) or in at least five analytical
days (interday assay), one of which was in the subsequent
week. Precision was defined as the relative standard deviation
(RSD%), while accuracy was defined as relative error (RE%),
both not exceeding 15%.
Recoveries were calculated by adding known concentra-
tions of GSH and Cys to the organ before submitting it to the
processing steps of the method, and the final concentration
of each sample represented the mean of five measurements.
Results are provided as the difference between the measured
and the theoretical values and expressed as percentage of
recovery.
2.7. Sample Stability. Sample stability was determined by
analyzing organs that were excised, processed, and left for 4 h
at room temperature or for 8 h at 4∘C or after three freeze-
thaw cycles. Sample stability was also evaluated in organs
that were excised and frozen in the precipitating solution at
−80∘C for 3 months. Stability sample results should be within
15% of the analyte concentration encountered in the sample
immediately processed.
3. Results and Discussion
Selective, sensitive, and validated analytical methods for the
quantitative evaluation of GSH and other thiol species are
critical for determination of redox state in experimental
models and the successful conduct of preclinical and/or
clinical pharmacology studies employingmolecules to restore
GSH levels that can be altered in pathological conditions
[2, 7]. Validating bioanalytical methods demonstrates that
a particular method used for quantitative measurement of
analytes in a given biological matrix (e.g., mouse organs) is
reliable and reproducible. Fundamental parameters for this
validation include the following: selectivity, sensitivity, accu-
racy, precision, reproducibility, and stability. Unfortunately,
only a few methods for the determination of GSH and Cys
in biological samples have been validated [9, 10]. In this
paper, we described validation of a simple, rapid, sensitive,
and cost-effective RP-HPLC method for the simultaneous
determination of Cys and GSH in different mouse organs
according to US and European standards, which can make
it of interest to readers who have to measure tissue GSH.
3.1. Selectivity. Selectivity is the ability of an analytical
method to differentiate and quantify the analyte in the pres-
ence of other components in the sample. The retention times
of Cys andGSHwere 6.7±0.4 and 14.8±0.5min, respectively.
No significant interference from endogenous substances was
observed at the retention times of the compounds studied.
Figure 1 shows a representative chromatogram of GSH and
Cys standards (a) and mouse spleen (b). The chromatograms
of other organs were comparable to spleen chromatograms
(data not shown).
3.2. Linearity and LLOQ. The standards used for the calibra-
tion curve were diluted either in water or in the precipitating
solution used to precipitate the organ proteins, obtaining
two comparable curves. Figure 2 shows the typical calibration
curves and linearity ranges for Cys (a) and GSH (b) diluted in
the precipitating solution. The calibration curves were linear
in the range of 0.313–50𝜇Mand 1.25–80𝜇MforCys andGSH,
respectively.
The LLOQ for Cys was 0.313 𝜇M, and the precision and
accuracy were less than 8% and within ±5%, respectively.The
LLOQ forGSHwas 1.25𝜇Mwith a precision less than 11% and
an accuracy lower than ±9%.
3.3. Sample Stability. Stability of thiol compounds during
prolonged storage of the tissues in the protein precipitating
buffer or of the deproteinized tissue homogenates is a pre-
requisite for reliable analysis in experimental setting. Stability
was evaluated in samples stored in different conditions as
described in Section 2.The results obtained showed that there
was no significant difference in the peak areas of Cys andGSH
demonstrating the high stability of these thiol species and
the validity of the sample preparation protocol in preventing
their conversions (Table 1). In the first column values are
referred to organs left immersed in the protein precipitating
solution. In the second, third, and fourth column values are
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Table 1: Stability of Cys and GSH in mouse organs.
Sample −80
∘C
3 months
RT
4 h
4∘C
8 h
Three
freeze-thaw cycles
Cys
Spleen 101.1 ± 4.2 97.6 ± 3.0 99.3 ± 2.9 98.7 ± 1.0
Lymph nodes 97.8 ± 4.6 98.7 ± 7.8 99.8 ± 1.9 98.4 ± 3.9
Pancreas 97.6 ± 2.2 103.0 ± 3.2 96.9 ± 1.8 98.9 ± 1.4
Brain 99.1 ± 2.3 98.4 ± 1.4 99.0 ± 5.1 98.5 ± 3.9
GSH
Spleen 99.9 ± 2.4 97.7 ± 1.7 98.9 ± 2.9 99.2 ± 1.9
Lymph nodes 98.9 ± 1.5 97.9 ± 2.3 99.1 ± 6.9 100.1 ± 1.9
Pancreas 99.3 ± 4.0 97.9 ± 2.0 98.0 ± 3.5 98.4 ± 4.1
Brain 99.6 ± 2.4 99.9 ± 7.5 99.1 ± 7.3 98.7 ± 1.4
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Figure 2: Calibration curves of Cys (a) and GSH (b) diluted in the solution used to precipitate organ proteins. Standards solutions were
quantified through spectrophotometer readings at 412 nm as described in Section 2.
referred to as deproteinized organ homogenates (RT: room
temperature). Values are the mean ± SD of 5 animals per
organ. Stability samples have been compared with the same
samples immediately processed and analyzed.
3.4. Precision, Accuracy, and Recovery. The accuracy of an
analytical method describes the closeness of mean test results
obtained by the method to the actual concentration of
the analyte, while the precision describes the closeness of
individual measures of an analyte when the procedure is
applied repeatedly to a single sample.
The recovery of an analyte in an assay is the detector
response obtained from an amount of the analyte added
to and extracted from the biological matrix (mouse organ),
compared to the detector response obtained for the true
concentration of the analyte in solvent.
We evaluated the precision, accuracy, and recovery of the
entiremethod by analyzing tissue samples spikedwith 40 𝜇M,
20𝜇M, or 2.5 𝜇M of Cys or with 60𝜇M, 20 𝜇M, or 5 𝜇M of
GSH. Each concentration was tested five times, and the data
of the assay are shown in Table 2. All the results of the tested
samples were within 15%,meeting the acceptable criterion. In
particular, in all tissue samples, the intraday precision (𝑛 = 5)
was less than 11%,while the interday precision (𝑛 = 5) was less
than 14% for both thiol species.
The accuracies of all the analyzed samples were less than
9% for both thiol species, except for brain spiked with 5𝜇M
of GSH in which case it was less than 14%, indicating that the
developed method is accurate and reliable.
For the recovery, the concentration in the spiked samples
was expressed as a percentage of the predicted concentration,
which was calculated as the sum of the added concentration
and the endogenous level of the analyte in the unspiked
sample. The mean extraction recoveries (𝑛 = 5) in all
organ samples were more 93% and 90% for Cys and GSH,
respectively, except in the brain spiked with 5𝜇MGSHwhere
the recovery was more than 86%. These results indicate that
the recoveries of both analytes were consistent and repro-
ducible and, in comparison to other HPLC-UV methods
used for Cys and GSH determination in biological fluids
[10], a higher recovery for both thiol species was obtained.
Another advantage of the method is represented by the use of
DTNB as derivatizing agent requiring shorter derivatization
times. Cys and GSH were also quantified in tissue specimens
by a chromatographic system equipped with a fluorescent
detector [9], but HPLC with a UV detector belongs to the
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Table 2: Summary of precision, accuracy, and recovery of the assay for GSH and Cys in mouse spleens, lymph nodes, pancreas, and brains
(𝑛 = 5).
Sample Concentration (𝜇M) Intraday (RSD%) Interday (RSD%) Accuracy (RE%) Recovery (%, mean ± SD)
Cys
Spleen
2.5 4.6 11.7 3.8 98.4 ± 1.3
20 5.3 8.0 5.8 96.8 ± 2.4
40 4.6 3.9 2.6 97.7 ± 2.1
Lymph nodes
2.5 6.9 8.9 5.1 97.0 ± 2.3
20 9.0 12.9 4.8 96.8 ± 2.6
40 5.0 11.7 6.2 93.9 ± 5.7
Pancreas
2.5 9.1 10.7 4.3 94.2 ± 5.6
20 7.5 6.8 8.5 94.5 ± 4.2
40 6.2 9.9 5.7 95.6 ± 2.7
Brain
2.5 9.7 6.7 4.6 95.9 ± 2.6
20 10.3 10.6 3.4 94.5 ± 4.0
40 8.7 11.8 6.7 96.4 ± 2.8
GSH
Spleen
5 3.3 7.5 3.5 92.7 ± 2.2
20 10.8 9.7 3.3 93.5 ± 4.6
60 9.0 12.4 1.9 94.7 ± 5.2
Lymph nodes
5 10.8 12.4 8.9 90.4 ± 2.0
20 1.9 6.2 3.7 96.4 ± 1.5
60 1.5 9.7 4.5 93.7 ± 4.8
Pancreas
5 9.9 12.8 3.3 91.4 ± 2.8
20 7.5 9.4 5.0 97.4 ± 3.2
60 9.3 13.7 6.4 91.1 ± 6.3
Brain
5 2.6 12.6 13.7 86.5 ± 5.0
20 4.4 10.7 1.2 98.2 ± 3.7
60 9.0 8.1 5.3 94.3 ± 7.2
standard instrumentation of an analytical laboratory not
requiring particular expensive maintenance.
3.5. Determination of Cys and GSH in Organs of Differ-
ent Mouse Strains. The validated method was successfully
applied to determine the concentrations of Cys and GSH
in the spleen, lymph nodes, pancreas, and brain of ICR
(CD-1), BALB/cJ, and C57BL/6N mice. The data reported
in Figure 3 show similar content of GSH (right) in the
spleen (a), pancreas (c), and brain (d) of all strains, while
a lower content of GSH was found in the lymph nodes (b)
of BALB/cJ. The concentration of Cys (left) found in spleen
(a) and pancreas (c) was lower in this strain than that in
the other ones; moreover the brain was assayed for Cys
but it was not detected (d) and in only one lymph node
sample (b) it was detectable. This is likely due to the lower
concentration of Cys in these two organs of BALB/Cj mice;
moreover, we can observe that in this strain Cys levels were
lower compared to the other strains, even when measured
above LLOQ. The applicability of the proposed method was
assessed through the analysis of GSH and Cys in other mouse
organs such as liver, kidney, lungs, and heart (Supplementary
Table in the Supplementary Material available online at
http://dx.doi.org/10.1155/2016/1746985) as well as the analysis
of GSH-replenishing molecules containing –SH groups
which were identified and clearly distinguished from GSH
and Cys [18].
These data provide reliable reference measurements of
GSH and Cys in the spleen, lymph nodes, pancreas, and
brain of three mouse strains widely used in preclinical
studies. Particularly, the data reported are a valuable resource
for investigating the role of GSH in modulating several
intracellular processes, from oxidative damage to immune
responses, as well as the effects of drugs and toxic compounds
on glutathione metabolism.
4. Conclusions
Results obtained from validation of the RP-HPLC method
herein described show that the method is accurate, reliable,
consistent, and reproducible. Moreover, the sample prepa-
ration and the extraction procedure developed allow high
stability of Cys and GSH in the samples preventing their
conversions. The main advantages of the present method
are validation, high recovery, simplicity, short derivatization
times, and low analytical costs. Therefore, this method is
particularly suitable for reliable routine measurement of
thiols in mouse organs and it can be used in all of those
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Figure 3: Quantification of Cys (left) and GSH (right) by HPLC in spleens (a), lymph nodes (b), pancreas (c), and brains (d) of ICR (CD-1)
(𝑛 = 5), C57BL/6N (𝑛 = 5), and BALB/Cj (𝑛 = 4) mice.
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animal models mimicking human diseases characterized by
GSH imbalance to both study disease processes and develop
therapies including GSH-based antioxidant treatment.
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